Mixed Connective Tissue Disease (MCTD)

Mixed Connective Tissue Disease (MCTD) is a rare autoimmune disorder that affects the body's connective tissues, which provide support and structure to organs and other tissues. It involves features of several diseases, including lupus, scleroderma, and polymyositis, causing a mix of symptoms. The condition mainly impacts the skin, joints, and muscles, leading to pain, swelling, and stiffness. It can also affect internal organs such as the lungs and heart, potentially causing serious complications. The disease is characterized by the presence of specific antibodies in the blood, which mistakenly attack the body's own tissues. Symptoms often develop gradually and can vary widely between individuals.

Mixed Connective Tissue Disease (MCTD) is a systemic autoimmune disorder characterized by overlapping clinical features of systemic lupus erythematosus, systemic sclerosis, and polymyositis. It is caused by an autoimmune response involving the production of high titers of anti-U1 ribonucleoprotein (RNP) antibodies, which are considered a serologic hallmark. The disease primarily affects the skin, joints, muscles, and vascular system, with common manifestations including Raynaud phenomenon, swollen hands, arthritis, and myositis. Pulmonary hypertension and interstitial lung disease are major causes of morbidity and mortality. The pathogenesis involves immune complex deposition and chronic inflammation leading to tissue damage. Diagnosis is important due to the distinct clinical course and treatment considerations compared to other connective tissue diseases.